Salvatore J. Salamone

Dr. Salamone has more than 30 years of experience in the health care and medical device industries. Prior to founding Saladax in 2004, Dr. Salamone was Vice President of Research and Development at Roche Diagnostics where he was responsible for North American research and development efforts for the Laboratory Systems Division. During his 17-year tenure at Roche, Dr. Salamone’s efforts resulted in the launch of seven major reagent product lines, comprised of more than 70 FDA-approved products and more than 200 instrument applications. At Saladax Dr. Salamone’s group has developed proprietary positions in the field of oncology and psychiatry drug management. These assays address unmet medical needs in providing precision treatment. Dr. Salamone is recognized globally in the field of drug monitoring, having authored more than 100 publications, including articles, textbook chapters, and books, and is also the holder of 41 issued US patents and the corresponding international patents. He has received numerous awards including the 2021 C.E. Pippenger Award for Outstanding Contributions to Therapeutic Drug Monitoring. In 2016 he was inducted into the prestige’s New Jersey Inventors Hall of Fame. Dr. Salamone earned two bachelor’s degrees from Villanova University, a master’s and a Ph.D. degree from Rutgers University, and was a Science Engineering Research Council (SERC) Post-Doctoral Fellow at Oxford University.